Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity What the evidence suggests: Those taking lower doses of GLP-1s may experience reduced side effects
GLP-1RAs can reduce the IL-6/STAT3 signaling pathway and enhance the cytotoxicity of NK and CD8 + T cells, potentially promoting the elimination of cancer cells (Lu et al., 2021
Dont ignore warning signs
however, individual requirements may vary based on treatment response, existing digestive health, and the presence of gastrointestinal side effects
Yes, I love water activities
Taking your dose early or late can cause peaks and valleys. A peak might lead to a day of intense nausea, while a valleythe end of a long gap between dosesmight lead to a return of food noise or increased hunger